What death panels? FDA begins process to revoke approval for expensive breast cancer drug Avastin
Not a lot of details have emerged yet about the FDA's decison to revoke approval for Avastin, aside from this brief notice at the Washington Post. Yesterday, the Examiner editorialized against this development: On Friday, the Food and Drug Administration could doom thousands of breast cancer victims. The FDA will be...
No comments:
Post a Comment